Global Radiotherapy Market - 2025 -2033
Radiotherapy Market Size
The global radiotherapy market was valued at US$ 6.17 Billion in 2023. The market size reached US$ 6.48 Billion in 2024 and is expected to reach US$ 10.56 Billion by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.
Radiotherapy Market Overview
Radiotherapy is a vital cancer treatment modality that uses high-energy radiation, such as X-rays, gamma rays, or proton beams, to destroy cancer cells or inhibit their growth. It can be administered externally through external beam radiation therapy (EBRT) or internally via brachytherapy.
The radiotherapy market is being driven by several key factors, including the rising global prevalence of cancer, growing awareness of radiotherapy's effectiveness, advancements in treatment technology, and increasing investment in healthcare infrastructure. Opportunities lie in the continued development of more precise and less toxic radiation techniques, integration of artificial intelligence for treatment planning, and expanding access in emerging markets.
North America currently dominates the radiotherapy market due to its high cancer burden, advanced healthcare systems, and early adoption of cutting-edge technology. Meanwhile, the Asia-Pacific region is the fastest-growing, driven by rapidly increasing cancer rates, government-led healthcare expansion, improved access to advanced treatments, and a surge in regional investments and collaborations in the medical technology sector.
Radiotherapy Market Dynamics: Drivers & Restraints
Drivers:
Rising prevalence of cancers is significantly driving the radiotherapy market growth
The rising prevalence of cancers worldwide is a key driver of growth in the radiotherapy market. As cancer cases continue to increase due to factors such as aging populations, lifestyle-related risks, and improved diagnostic techniques, the demand for effective and accessible treatment options has intensified. For instance, according to the International Agency for Research on Cancer, it is stated that around 20 million cancer cases were incident, and it is estimated that around 32.6 million new cancer cases will be reported.
Radiotherapy plays a vital role in cancer management, either as a standalone therapy or in combination with surgery and chemotherapy. Its ability to precisely target and destroy cancer cells while preserving surrounding healthy tissue makes it a preferred choice across various cancer types. This growing patient pool, coupled with advancements in radiotherapy technology, is expected to propel market expansion significantly in the coming years.
The increasing technological advancements are expected to boost the radiotherapy market
Increasing technological advancements are expected to significantly boost the radiotherapy market by enhancing treatment precision, efficiency, and patient outcomes. Innovations such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), and proton beam therapy have revolutionized cancer treatment by allowing higher radiation doses to be delivered directly to tumors while minimizing damage to surrounding healthy tissue. These advanced techniques reduce side effects and improve recovery times, making radiotherapy a more attractive option for both patients and healthcare providers.
For instance, in May 2025, GE HealthCare announced plans to expand its radiation oncology portfolio and unveiled its new AI-powered MR Contour DL at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company also highlighted advancements in its Intelligent Radiation Therapy (iRT) software, designed to streamline complex workflows, reduce the time from diagnosis to treatment, and deliver more precise radiation therapy.
Additionally, the integration of artificial intelligence (AI), machine learning, and real-time imaging in treatment planning and delivery is further optimizing accuracy and personalization of care. As these technologies become more widely available and cost-effective, their adoption is expected to accelerate globally, driving growth and expanding the scope of radiotherapy in cancer management.
Restraint:
The high device and treatment costs are hampering the growth of the radiotherapy market
High device and treatment costs are expected to hinder the growth of the radiotherapy market, particularly in low- and middle-income regions. Advanced radiotherapy equipment such as linear accelerators, proton therapy systems, and stereotactic radiotherapy machines requires substantial capital investment, ongoing maintenance, and specialized infrastructure. Additionally, the cost of treatment itself can be financially burdensome for patients without comprehensive insurance coverage.
Opportunity:
The expansion into emerging regions is expected to create a lucrative opportunity for the radiotherapy market
The expansion into emerging regions is expected to create a lucrative opportunity for the radiotherapy market due to a combination of rising cancer incidence, improving healthcare infrastructure, and growing government support. Countries in Asia-Pacific, Latin America, the Middle East, and parts of Africa are experiencing a surge in cancer diagnoses, driven by aging populations, lifestyle changes, and better screening programs.
At the same time, these regions are increasingly investing in healthcare modernization, including the development of cancer care centers and the procurement of advanced radiotherapy equipment. International manufacturers are also forming partnerships and establishing local production facilities to reduce costs and improve access.
Radiotherapy Market, Segment Analysis
The global radiotherapy market is segmented based on type, technology, product type, form, end-user, and region.
The external beam radiation therapy from the type segment is expected to hold 38.04% of the market share in 2024 in the radiotherapy market
The external beam radiation therapy (EBRT) segment is expected to dominate the radiotherapy market due to its widespread use, technological advancements, and clinical effectiveness across a broad range of cancers. EBRT is a non-invasive technique that delivers high-energy radiation precisely to tumor sites while minimizing damage to surrounding healthy tissue.
It is commonly used in the treatment of cancers such as breast, prostate, lung, and head and neck, making it the most versatile and widely applicable form of radiotherapy. The growing adoption of advanced EBRT techniques has further improved treatment accuracy and outcomes. Additionally, its relative affordability compared to other forms like proton therapy contributes to its dominant position in both developed and emerging markets.
Radiotherapy Market, Geographical Analysis
North America is expected to dominate the global radiotherapy market with a 40.2% share in 2024
North America is likely to dominate the radiotherapy market for a variety of factors, including high cancer prevalence, a strong healthcare infrastructure, technological breakthroughs, and advantageous reimbursement policies. The region reports a large number of cancer cases each year, particularly prostate, breast, and lung cancers, which increases the demand for effective treatment options such as radiotherapy. According to the International Agency for Research on Cancer, approximately 2.67 million new cancer cases were reported, and the number of new cancer cases is expected to increase by 3.83 million by 2045.
Furthermore, North America benefits from the early adoption of modern radiotherapy methods like image-guided radiotherapy (IGRT), proton therapy, and stereotactic body radiotherapy (SBRT). Leading market companies, ongoing R&D investment, and government backing through initiatives such as the Cancer Moonshot program all help to drive innovation and accessibility in therapy. Well-established healthcare facilities and a wide range of experienced specialists improve treatment outcomes and patient confidence. Furthermore, robust insurance coverage and reimbursement arrangements, particularly in the United States and Canada, lessen patients' financial burden, making radiotherapy more accessible.
Asia-Pacific is growing at the fastest pace in the radiotherapy market holding 21.8% of the market share
Asia-Pacific is projected to be the fastest-growing region in the radiotherapy market, driven by a sharp rise in cancer incidence, increased healthcare investments, and rapid adoption of advanced technologies. With populations aging and lifestyle-related risk factors becoming more prevalent, the region is experiencing a surge in cancer diagnoses, prompting governments and private sectors to expand oncology infrastructure. Countries like China, India, and Japan are investing heavily in radiotherapy equipment and workforce development under national health initiatives.
Radiotherapy Market Competitive Landscape
Top companies in the radiotherapy market include Accuracy Incorporated, Varian, Elekta AB, IBA (Ion Beam Applications), Mevion Medical Systems, Inc., GE Healthcare, Hitachi, Ltd., Canon Inc., ViewRay Systems, Inc., among others.
Radiotherapy Market, Key Developments
The global radiotherapy market was valued at US$ 6.17 Billion in 2023. The market size reached US$ 6.48 Billion in 2024 and is expected to reach US$ 10.56 Billion by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.
Radiotherapy Market Overview
Radiotherapy is a vital cancer treatment modality that uses high-energy radiation, such as X-rays, gamma rays, or proton beams, to destroy cancer cells or inhibit their growth. It can be administered externally through external beam radiation therapy (EBRT) or internally via brachytherapy.
The radiotherapy market is being driven by several key factors, including the rising global prevalence of cancer, growing awareness of radiotherapy's effectiveness, advancements in treatment technology, and increasing investment in healthcare infrastructure. Opportunities lie in the continued development of more precise and less toxic radiation techniques, integration of artificial intelligence for treatment planning, and expanding access in emerging markets.
North America currently dominates the radiotherapy market due to its high cancer burden, advanced healthcare systems, and early adoption of cutting-edge technology. Meanwhile, the Asia-Pacific region is the fastest-growing, driven by rapidly increasing cancer rates, government-led healthcare expansion, improved access to advanced treatments, and a surge in regional investments and collaborations in the medical technology sector.
Radiotherapy Market Dynamics: Drivers & Restraints
Drivers:
Rising prevalence of cancers is significantly driving the radiotherapy market growth
The rising prevalence of cancers worldwide is a key driver of growth in the radiotherapy market. As cancer cases continue to increase due to factors such as aging populations, lifestyle-related risks, and improved diagnostic techniques, the demand for effective and accessible treatment options has intensified. For instance, according to the International Agency for Research on Cancer, it is stated that around 20 million cancer cases were incident, and it is estimated that around 32.6 million new cancer cases will be reported.
Radiotherapy plays a vital role in cancer management, either as a standalone therapy or in combination with surgery and chemotherapy. Its ability to precisely target and destroy cancer cells while preserving surrounding healthy tissue makes it a preferred choice across various cancer types. This growing patient pool, coupled with advancements in radiotherapy technology, is expected to propel market expansion significantly in the coming years.
The increasing technological advancements are expected to boost the radiotherapy market
Increasing technological advancements are expected to significantly boost the radiotherapy market by enhancing treatment precision, efficiency, and patient outcomes. Innovations such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), and proton beam therapy have revolutionized cancer treatment by allowing higher radiation doses to be delivered directly to tumors while minimizing damage to surrounding healthy tissue. These advanced techniques reduce side effects and improve recovery times, making radiotherapy a more attractive option for both patients and healthcare providers.
For instance, in May 2025, GE HealthCare announced plans to expand its radiation oncology portfolio and unveiled its new AI-powered MR Contour DL at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company also highlighted advancements in its Intelligent Radiation Therapy (iRT) software, designed to streamline complex workflows, reduce the time from diagnosis to treatment, and deliver more precise radiation therapy.
Additionally, the integration of artificial intelligence (AI), machine learning, and real-time imaging in treatment planning and delivery is further optimizing accuracy and personalization of care. As these technologies become more widely available and cost-effective, their adoption is expected to accelerate globally, driving growth and expanding the scope of radiotherapy in cancer management.
Restraint:
The high device and treatment costs are hampering the growth of the radiotherapy market
High device and treatment costs are expected to hinder the growth of the radiotherapy market, particularly in low- and middle-income regions. Advanced radiotherapy equipment such as linear accelerators, proton therapy systems, and stereotactic radiotherapy machines requires substantial capital investment, ongoing maintenance, and specialized infrastructure. Additionally, the cost of treatment itself can be financially burdensome for patients without comprehensive insurance coverage.
Opportunity:
The expansion into emerging regions is expected to create a lucrative opportunity for the radiotherapy market
The expansion into emerging regions is expected to create a lucrative opportunity for the radiotherapy market due to a combination of rising cancer incidence, improving healthcare infrastructure, and growing government support. Countries in Asia-Pacific, Latin America, the Middle East, and parts of Africa are experiencing a surge in cancer diagnoses, driven by aging populations, lifestyle changes, and better screening programs.
At the same time, these regions are increasingly investing in healthcare modernization, including the development of cancer care centers and the procurement of advanced radiotherapy equipment. International manufacturers are also forming partnerships and establishing local production facilities to reduce costs and improve access.
Radiotherapy Market, Segment Analysis
The global radiotherapy market is segmented based on type, technology, product type, form, end-user, and region.
The external beam radiation therapy from the type segment is expected to hold 38.04% of the market share in 2024 in the radiotherapy market
The external beam radiation therapy (EBRT) segment is expected to dominate the radiotherapy market due to its widespread use, technological advancements, and clinical effectiveness across a broad range of cancers. EBRT is a non-invasive technique that delivers high-energy radiation precisely to tumor sites while minimizing damage to surrounding healthy tissue.
It is commonly used in the treatment of cancers such as breast, prostate, lung, and head and neck, making it the most versatile and widely applicable form of radiotherapy. The growing adoption of advanced EBRT techniques has further improved treatment accuracy and outcomes. Additionally, its relative affordability compared to other forms like proton therapy contributes to its dominant position in both developed and emerging markets.
Radiotherapy Market, Geographical Analysis
North America is expected to dominate the global radiotherapy market with a 40.2% share in 2024
North America is likely to dominate the radiotherapy market for a variety of factors, including high cancer prevalence, a strong healthcare infrastructure, technological breakthroughs, and advantageous reimbursement policies. The region reports a large number of cancer cases each year, particularly prostate, breast, and lung cancers, which increases the demand for effective treatment options such as radiotherapy. According to the International Agency for Research on Cancer, approximately 2.67 million new cancer cases were reported, and the number of new cancer cases is expected to increase by 3.83 million by 2045.
Furthermore, North America benefits from the early adoption of modern radiotherapy methods like image-guided radiotherapy (IGRT), proton therapy, and stereotactic body radiotherapy (SBRT). Leading market companies, ongoing R&D investment, and government backing through initiatives such as the Cancer Moonshot program all help to drive innovation and accessibility in therapy. Well-established healthcare facilities and a wide range of experienced specialists improve treatment outcomes and patient confidence. Furthermore, robust insurance coverage and reimbursement arrangements, particularly in the United States and Canada, lessen patients' financial burden, making radiotherapy more accessible.
Asia-Pacific is growing at the fastest pace in the radiotherapy market holding 21.8% of the market share
Asia-Pacific is projected to be the fastest-growing region in the radiotherapy market, driven by a sharp rise in cancer incidence, increased healthcare investments, and rapid adoption of advanced technologies. With populations aging and lifestyle-related risk factors becoming more prevalent, the region is experiencing a surge in cancer diagnoses, prompting governments and private sectors to expand oncology infrastructure. Countries like China, India, and Japan are investing heavily in radiotherapy equipment and workforce development under national health initiatives.
Radiotherapy Market Competitive Landscape
Top companies in the radiotherapy market include Accuracy Incorporated, Varian, Elekta AB, IBA (Ion Beam Applications), Mevion Medical Systems, Inc., GE Healthcare, Hitachi, Ltd., Canon Inc., ViewRay Systems, Inc., among others.
Radiotherapy Market, Key Developments
- In January 2025, RefleXion Medical announced the launch of the BIOGUIDE-X2 clinical study. The study aims to expand the clinical indications for SCINTIX biology-guided radiotherapy and is being conducted at Hackensack Meridian John Theurer Cancer Center, in collaboration with Georgetown’s Lombardi Comprehensive Cancer Center, an NCI-designated comprehensive cancer center.
- In September 2024, RefleXion Medical, Inc. announced that Smilow Cancer Hospital had successfully delivered the world’s first radiotherapy treatment plan that integrates multiple radiotherapy modalities for a patient with metastatic cancer.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
3.2. Snippet by Type
3.3. Snippet by Technology
3.4. Snippet by Product Type
3.5. Snippet by Form
3.6. Snippet by End-User
3.7. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Cancers
4.1.1.2. Increasing Technological Advancements
4.1.1.3. Non-invasive and Cost-Effective Preference
4.1.2. Restraints
4.1.2.1. High Device and Treatment Costs
4.1.2.2. Regulatory and Safety Hurdles
4.1.2.3. Competing Alternative Therapies
4.1.3. Opportunity
4.1.3.1. Expansion into Emerging Regions
4.1.3.2. AI and Digital Integration
4.1.4. Impact Analysis
5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established Leaders with the Largest Marketing Brand
5.1.3. Market Leaders with Established Products
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South America
5.3.5. Middle East & Africa
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Pipeline Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
5.9. Unmet Needs and Gaps
5.10. Recommended Strategies for Market Entry and Expansion
5.11. Pricing Analysis and Price Dynamics
6. RADIOTHERAPY MARKET, BY TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Teletherapy (External)*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Brachytherapy (Internal)
6.4. Systemic Radiation Therapy
7. RADIOTHERAPY MARKET, BY DIAGNOSIS TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis Type
7.1.2. Market Attractiveness Index, By Diagnosis Type
7.2. Image-Guided Radiotherapy (IGRT)*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Intensity Modulated Radiotherapy (IMRT)
7.4. Stereotactic Technology
7.5. Proton Beam Therapy
7.6. 3d Conformal Radiotherapy (3d Crt)
7.7. Others
8. RADIOTHERAPY MARKET, BY PRODUCT TYPE
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.1.2. Market Attractiveness Index, By Product Type
8.2. Compact Advanced Radiotherapy Systems*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Proton Therapy Systems
8.4. Conventional Radiotherapy Systems
8.5. Lobenguane (I-131)
8.6. Samarium-153
8.7. Rhenium-186
8.8. Others
9. RADIOTHERAPY MARKET, BY FORM
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
9.1.2. Market Attractiveness Index, By Form
9.2. X-rays*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Gamma Rays
9.4. Particles
10. RADIOTHERAPY MARKET, BY END-USER
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Cancer Centers
10.4. Others
11. RADIOTHERAPY MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
12. INTRODUCTION
12.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.1. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13. MARKET SIZE ANALYSIS AND Y-O-Y GROWTH ANALYSIS (%), BY COUNTRY
13.1. U.S.
13.1.1. Canada
13.1.1.1. Mexico
13.2. Europe
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.8.1. Germany
13.2.8.2. UK
13.2.8.3. France
13.2.8.4. Spain
13.2.8.5. Italy
13.2.8.6. Rest of Europe
13.3. Asia-Pacific
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.8.1. China
13.3.8.2. India
13.3.8.3. Japan
13.3.8.4. South Korea
13.3.8.5. Rest of Asia-Pacific
13.4. South America
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.8.1. Brazil
13.4.8.2. Argentina
13.4.8.3. Rest of South America
13.5. Middle East and Africa
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
14. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
15. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
15.1. Market Share Analysis and Positioning Matrix
15.2. Strategic Partnerships, Mergers & Acquisitions
15.3. Key Developments in Product Portfolios and Innovations
15.4. Company Benchmarking
16. COMPANY PROFILES
16.1. Accuracy Incorporated*
16.1.1. Company Overview
16.1.2. Product Portfolio
16.1.2.1. Product Description
16.1.2.2. Product Key Performance Indicators (KPIs)
16.2. Financial Overview
16.2.1. Company Revenue
16.2.1.1. Geographical Revenue Shares
16.2.1.1.1. Revenue Forecasts
16.2.1.2. Key Developments
16.2.1.2.1. Mergers & Acquisitions
16.2.1.2.2. Key Product Development Activities
16.2.1.2.3. Regulatory Approvals, etc.
16.2.1.3. SWOT Analysis
16.2.2. Varian
16.2.3. Elekta AB
16.2.4. IBA (Ion Beam Applications)
16.2.5. Mevion Medical Systems, Inc.
16.2.6. GE Healthcare
16.2.7. Hitachi, Ltd.
16.2.8. Canon Inc.
16.2.9. ViewRay Systems, Inc. (LIST NOT EXHAUSTIVE)
17. ASSUMPTIONS AND RESEARCH METHODOLOGY
17.1. Data Collection Methods
17.2. Data Triangulation
17.3. Forecasting Techniques
17.4. Data Verification and Validation
18. APPENDIX
18.1. About Us and Services
18.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
3.2. Snippet by Type
3.3. Snippet by Technology
3.4. Snippet by Product Type
3.5. Snippet by Form
3.6. Snippet by End-User
3.7. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Cancers
4.1.1.2. Increasing Technological Advancements
4.1.1.3. Non-invasive and Cost-Effective Preference
4.1.2. Restraints
4.1.2.1. High Device and Treatment Costs
4.1.2.2. Regulatory and Safety Hurdles
4.1.2.3. Competing Alternative Therapies
4.1.3. Opportunity
4.1.3.1. Expansion into Emerging Regions
4.1.3.2. AI and Digital Integration
4.1.4. Impact Analysis
5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established Leaders with the Largest Marketing Brand
5.1.3. Market Leaders with Established Products
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South America
5.3.5. Middle East & Africa
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Pipeline Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
5.9. Unmet Needs and Gaps
5.10. Recommended Strategies for Market Entry and Expansion
5.11. Pricing Analysis and Price Dynamics
6. RADIOTHERAPY MARKET, BY TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Teletherapy (External)*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Brachytherapy (Internal)
6.4. Systemic Radiation Therapy
7. RADIOTHERAPY MARKET, BY DIAGNOSIS TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis Type
7.1.2. Market Attractiveness Index, By Diagnosis Type
7.2. Image-Guided Radiotherapy (IGRT)*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Intensity Modulated Radiotherapy (IMRT)
7.4. Stereotactic Technology
7.5. Proton Beam Therapy
7.6. 3d Conformal Radiotherapy (3d Crt)
7.7. Others
8. RADIOTHERAPY MARKET, BY PRODUCT TYPE
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.1.2. Market Attractiveness Index, By Product Type
8.2. Compact Advanced Radiotherapy Systems*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Proton Therapy Systems
8.4. Conventional Radiotherapy Systems
8.5. Lobenguane (I-131)
8.6. Samarium-153
8.7. Rhenium-186
8.8. Others
9. RADIOTHERAPY MARKET, BY FORM
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
9.1.2. Market Attractiveness Index, By Form
9.2. X-rays*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Gamma Rays
9.4. Particles
10. RADIOTHERAPY MARKET, BY END-USER
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Cancer Centers
10.4. Others
11. RADIOTHERAPY MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
12. INTRODUCTION
12.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.1. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13. MARKET SIZE ANALYSIS AND Y-O-Y GROWTH ANALYSIS (%), BY COUNTRY
13.1. U.S.
13.1.1. Canada
13.1.1.1. Mexico
13.2. Europe
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.8.1. Germany
13.2.8.2. UK
13.2.8.3. France
13.2.8.4. Spain
13.2.8.5. Italy
13.2.8.6. Rest of Europe
13.3. Asia-Pacific
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.8.1. China
13.3.8.2. India
13.3.8.3. Japan
13.3.8.4. South Korea
13.3.8.5. Rest of Asia-Pacific
13.4. South America
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.8.1. Brazil
13.4.8.2. Argentina
13.4.8.3. Rest of South America
13.5. Middle East and Africa
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
14. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
15. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
15.1. Market Share Analysis and Positioning Matrix
15.2. Strategic Partnerships, Mergers & Acquisitions
15.3. Key Developments in Product Portfolios and Innovations
15.4. Company Benchmarking
16. COMPANY PROFILES
16.1. Accuracy Incorporated*
16.1.1. Company Overview
16.1.2. Product Portfolio
16.1.2.1. Product Description
16.1.2.2. Product Key Performance Indicators (KPIs)
16.2. Financial Overview
16.2.1. Company Revenue
16.2.1.1. Geographical Revenue Shares
16.2.1.1.1. Revenue Forecasts
16.2.1.2. Key Developments
16.2.1.2.1. Mergers & Acquisitions
16.2.1.2.2. Key Product Development Activities
16.2.1.2.3. Regulatory Approvals, etc.
16.2.1.3. SWOT Analysis
16.2.2. Varian
16.2.3. Elekta AB
16.2.4. IBA (Ion Beam Applications)
16.2.5. Mevion Medical Systems, Inc.
16.2.6. GE Healthcare
16.2.7. Hitachi, Ltd.
16.2.8. Canon Inc.
16.2.9. ViewRay Systems, Inc. (LIST NOT EXHAUSTIVE)
17. ASSUMPTIONS AND RESEARCH METHODOLOGY
17.1. Data Collection Methods
17.2. Data Triangulation
17.3. Forecasting Techniques
17.4. Data Verification and Validation
18. APPENDIX
18.1. About Us and Services
18.2. Contact Us
LIST OF TABLES
Table 1 Global Radiotherapy Market Value, By Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Radiotherapy Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Radiotherapy Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Radiotherapy Market Value, By Form, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Radiotherapy Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Radiotherapy Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Radiotherapy Market Value, By Type, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Radiotherapy Market Value, By Type, 2022-2033 (US$ Billion)
Table 9 Global Radiotherapy Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Radiotherapy Market Value, By Technology, 2022-2033 (US$ Billion)
Table 11 Global Radiotherapy Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Radiotherapy Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 13 Global Radiotherapy Market Value, By Form, 2025, 2029 & 2033 (US$ Billion)
Table 14 Global Radiotherapy Market Value, By Form, 2022-2033 (US$ Billion)
Table 15 Global Radiotherapy Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 16 Global Radiotherapy Market Value, By End-User, 2022-2033 (US$ Billion)
Table 17 Global Radiotherapy Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 18 Global Radiotherapy Market Value, By Region, 2022-2033 (US$ Billion)
Table 19 North America Radiotherapy Market Value, By Type, 2022-2033 (US$ Billion)
Table 20 North America Radiotherapy Market Value, By Technology, 2022-2033 (US$ Billion)
Table 21 North America Radiotherapy Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 North America Radiotherapy Market Value, By Form, 2022-2033 (US$ Billion)
Table 23 North America Radiotherapy Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 North America Radiotherapy Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Radiotherapy Market Value, By Type, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Radiotherapy Market Value, By Technology, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Radiotherapy Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Radiotherapy Market Value, By Form, 2022-2033 (US$ Billion)
Table 29 Asia-Pacific Radiotherapy Market Value, By End-User, 2022-2033 (US$ Billion)
Table 30 Asia-Pacific Radiotherapy Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 Europe Radiotherapy Market Value, By Type, 2022-2033 (US$ Billion)
Table 32 Europe Radiotherapy Market Value, By Technology, 2022-2033 (US$ Billion)
Table 33 Europe Radiotherapy Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 34 Europe Radiotherapy Market Value, By Form, 2022-2033 (US$ Billion)
Table 35 Europe Radiotherapy Market Value, By End-User, 2022-2033 (US$ Billion)
Table 36 Europe Radiotherapy Market Value, By Country, 2022-2033 (US$ Billion)
Table 37 South America Radiotherapy Market Value, By Type, 2022-2033 (US$ Billion)
Table 38 South America Radiotherapy Market Value, By Technology, 2022-2033 (US$ Billion)
Table 39 South America Radiotherapy Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 40 South America Radiotherapy Market Value, By Form, 2022-2033 (US$ Billion)
Table 41 South America Radiotherapy Market Value, By End-User, 2022-2033 (US$ Billion)
Table 42 South America Radiotherapy Market Value, By Country, 2022-2033 (US$ Billion)
Table 43 Middle East and Africa Radiotherapy Market Value, By Type, 2022-2033 (US$ Billion)
Table 44 Middle East and Africa Radiotherapy Market Value, By Technology, 2022-2033 (US$ Billion)
Table 45 Middle East and Africa Radiotherapy Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 46 Middle East and Africa Radiotherapy Market Value, By Form, 2022-2033 (US$ Billion)
Table 47 Middle East and Africa Radiotherapy Market Value, By End-User, 2022-2033 (US$ Billion)
Table 48 Middle East and Africa Radiotherapy Market Value, By Country, 2022-2033 (US$ Billion)
Table 49 Accuracy Incorporated: Overview
Table 50 Accuracy Incorporated: Product Portfolio
Table 51 Accuracy Incorporated: Key Developments
Table 52 Varian: Overview
Table 53 Varian: Product Portfolio
Table 54 Varian: Key Developments
Table 55 Elekta AB: Overview
Table 56 Elekta AB: Product Portfolio
Table 57 Elekta AB: Key Developments
Table 58 IBA (Ion Beam Applications): Overview
Table 59 IBA (Ion Beam Applications): Product Portfolio
Table 60 IBA (Ion Beam Applications): Key Developments
Table 61 Mevion Medical Systems, Inc.: Overview
Table 62 Mevion Medical Systems, Inc.: Product Portfolio
Table 63 Mevion Medical Systems, Inc.: Key Developments
Table 64 GE Healthcare: Overview
Table 65 GE Healthcare: Product Portfolio
Table 66 GE Healthcare: Key Developments
Table 67 Hitachi, Ltd.: Overview
Table 68 Hitachi, Ltd.: Product Portfolio
Table 69 Hitachi, Ltd.: Key Developments
Table 70 Canon Inc.: Overview
Table 71 Canon Inc.: Product Portfolio
Table 72 Canon Inc.: Key Developments
Table 73 ViewRay Systems, Inc.: Overview
Table 74 ViewRay Systems, Inc.: Product Portfolio
Table 75 ViewRay Systems, Inc.: Key Developments
Table 1 Global Radiotherapy Market Value, By Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Radiotherapy Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Radiotherapy Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Radiotherapy Market Value, By Form, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Radiotherapy Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Radiotherapy Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Radiotherapy Market Value, By Type, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Radiotherapy Market Value, By Type, 2022-2033 (US$ Billion)
Table 9 Global Radiotherapy Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Radiotherapy Market Value, By Technology, 2022-2033 (US$ Billion)
Table 11 Global Radiotherapy Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Radiotherapy Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 13 Global Radiotherapy Market Value, By Form, 2025, 2029 & 2033 (US$ Billion)
Table 14 Global Radiotherapy Market Value, By Form, 2022-2033 (US$ Billion)
Table 15 Global Radiotherapy Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 16 Global Radiotherapy Market Value, By End-User, 2022-2033 (US$ Billion)
Table 17 Global Radiotherapy Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 18 Global Radiotherapy Market Value, By Region, 2022-2033 (US$ Billion)
Table 19 North America Radiotherapy Market Value, By Type, 2022-2033 (US$ Billion)
Table 20 North America Radiotherapy Market Value, By Technology, 2022-2033 (US$ Billion)
Table 21 North America Radiotherapy Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 North America Radiotherapy Market Value, By Form, 2022-2033 (US$ Billion)
Table 23 North America Radiotherapy Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 North America Radiotherapy Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Radiotherapy Market Value, By Type, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Radiotherapy Market Value, By Technology, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Radiotherapy Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Radiotherapy Market Value, By Form, 2022-2033 (US$ Billion)
Table 29 Asia-Pacific Radiotherapy Market Value, By End-User, 2022-2033 (US$ Billion)
Table 30 Asia-Pacific Radiotherapy Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 Europe Radiotherapy Market Value, By Type, 2022-2033 (US$ Billion)
Table 32 Europe Radiotherapy Market Value, By Technology, 2022-2033 (US$ Billion)
Table 33 Europe Radiotherapy Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 34 Europe Radiotherapy Market Value, By Form, 2022-2033 (US$ Billion)
Table 35 Europe Radiotherapy Market Value, By End-User, 2022-2033 (US$ Billion)
Table 36 Europe Radiotherapy Market Value, By Country, 2022-2033 (US$ Billion)
Table 37 South America Radiotherapy Market Value, By Type, 2022-2033 (US$ Billion)
Table 38 South America Radiotherapy Market Value, By Technology, 2022-2033 (US$ Billion)
Table 39 South America Radiotherapy Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 40 South America Radiotherapy Market Value, By Form, 2022-2033 (US$ Billion)
Table 41 South America Radiotherapy Market Value, By End-User, 2022-2033 (US$ Billion)
Table 42 South America Radiotherapy Market Value, By Country, 2022-2033 (US$ Billion)
Table 43 Middle East and Africa Radiotherapy Market Value, By Type, 2022-2033 (US$ Billion)
Table 44 Middle East and Africa Radiotherapy Market Value, By Technology, 2022-2033 (US$ Billion)
Table 45 Middle East and Africa Radiotherapy Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 46 Middle East and Africa Radiotherapy Market Value, By Form, 2022-2033 (US$ Billion)
Table 47 Middle East and Africa Radiotherapy Market Value, By End-User, 2022-2033 (US$ Billion)
Table 48 Middle East and Africa Radiotherapy Market Value, By Country, 2022-2033 (US$ Billion)
Table 49 Accuracy Incorporated: Overview
Table 50 Accuracy Incorporated: Product Portfolio
Table 51 Accuracy Incorporated: Key Developments
Table 52 Varian: Overview
Table 53 Varian: Product Portfolio
Table 54 Varian: Key Developments
Table 55 Elekta AB: Overview
Table 56 Elekta AB: Product Portfolio
Table 57 Elekta AB: Key Developments
Table 58 IBA (Ion Beam Applications): Overview
Table 59 IBA (Ion Beam Applications): Product Portfolio
Table 60 IBA (Ion Beam Applications): Key Developments
Table 61 Mevion Medical Systems, Inc.: Overview
Table 62 Mevion Medical Systems, Inc.: Product Portfolio
Table 63 Mevion Medical Systems, Inc.: Key Developments
Table 64 GE Healthcare: Overview
Table 65 GE Healthcare: Product Portfolio
Table 66 GE Healthcare: Key Developments
Table 67 Hitachi, Ltd.: Overview
Table 68 Hitachi, Ltd.: Product Portfolio
Table 69 Hitachi, Ltd.: Key Developments
Table 70 Canon Inc.: Overview
Table 71 Canon Inc.: Product Portfolio
Table 72 Canon Inc.: Key Developments
Table 73 ViewRay Systems, Inc.: Overview
Table 74 ViewRay Systems, Inc.: Product Portfolio
Table 75 ViewRay Systems, Inc.: Key Developments
LIST OF FIGURES
Figure 1 Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Radiotherapy Market Share, By Type, 2024 & 2033 (%)
Figure 3 Global Radiotherapy Market Share, By Technology, 2024 & 2033 (%)
Figure 4 Global Radiotherapy Market Share, By Product Type, 2024 & 2033 (%)
Figure 5 Global Radiotherapy Market Share, By Form, 2024 & 2033 (%)
Figure 6 Global Radiotherapy Market Share, By End-User, 2024 & 2033 (%)
Figure 7 Global Radiotherapy Market Share, By Region, 2024 & 2033 (%)
Figure 8 Global Radiotherapy Market Y-o-Y Growth, By Type, 2023-2033 (%)
Figure 9 Teletherapy (External) Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 10 Brachytherapy (Internal) Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 11 Systemic Radiation Therapy Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 12 Global Radiotherapy Market Y-o-Y Growth, By Technology, 2023-2033 (%)
Figure 13 Image-Guided Radiotherapy (IGRT) Technology in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 14 Intensity Modulated Radiotherapy (IMRT) Technology in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 15 Stereotactic Technology Technology in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 16 Proton Beam Therapy Technology in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 17 3d Conformal Radiotherapy (3d Crt) Technology in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 18 Others Technology in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 19 Global Radiotherapy Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 20 Compact Advanced Radiotherapy Systems Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 21 Proton Therapy Systems Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 22 Conventional Radiotherapy Systems Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 23 Lobenguane (I-131) Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 24 Samarium-153 Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 25 Rhenium-186 Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 26 Others Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 27 Global Radiotherapy Market Y-o-Y Growth, By Form, 2023-2033 (%)
Figure 28 X-rays Form in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 29 Gamma Rays Form in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 30 Particles Form in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 31 Global Radiotherapy Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 32 Hospitals End-User in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 33 Cancer Centers End-User in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 34 Others End-User in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 35 Global Radiotherapy Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 36 North America Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 37 North America Radiotherapy Market Share, By Type, 2024 & 2033 (%)
Figure 38 North America Radiotherapy Market Share, By Technology, 2024 & 2033 (%)
Figure 39 North America Radiotherapy Market Share, By Product Type, 2024 & 2033 (%)
Figure 40 North America Radiotherapy Market Share, By Form, 2024 & 2033 (%)
Figure 41 North America Radiotherapy Market Share, By End-User, 2024 & 2033 (%)
Figure 42 North America Radiotherapy Market Share, By Country, 2024 & 2033 (%)
Figure 43 Asia-Pacific Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 44 Asia-Pacific Radiotherapy Market Share, By Type, 2024 & 2033 (%)
Figure 45 Asia-Pacific Radiotherapy Market Share, By Technology, 2024 & 2033 (%)
Figure 46 Asia-Pacific Radiotherapy Market Share, By Product Type, 2024 & 2033 (%)
Figure 47 Asia-Pacific Radiotherapy Market Share, By Form, 2024 & 2033 (%)
Figure 48 Asia-Pacific Radiotherapy Market Share, By End-User, 2024 & 2033 (%)
Figure 49 Asia-Pacific Radiotherapy Market Share, By Country, 2024 & 2033 (%)
Figure 50 Europe Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 51 Europe Radiotherapy Market Share, By Type, 2024 & 2033 (%)
Figure 52 Europe Radiotherapy Market Share, By Technology, 2024 & 2033 (%)
Figure 53 Europe Radiotherapy Market Share, By Product Type, 2024 & 2033 (%)
Figure 54 Europe Radiotherapy Market Share, By Form, 2024 & 2033 (%)
Figure 55 Europe Radiotherapy Market Share, By End-User, 2024 & 2033 (%)
Figure 56 Europe Radiotherapy Market Share, By Country, 2024 & 2033 (%)
Figure 57 South America Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 58 South America Radiotherapy Market Share, By Type, 2024 & 2033 (%)
Figure 59 South America Radiotherapy Market Share, By Technology, 2024 & 2033 (%)
Figure 60 South America Radiotherapy Market Share, By Product Type, 2024 & 2033 (%)
Figure 61 South America Radiotherapy Market Share, By Form, 2024 & 2033 (%)
Figure 62 South America Radiotherapy Market Share, By End-User, 2024 & 2033 (%)
Figure 63 South America Radiotherapy Market Share, By Country, 2024 & 2033 (%)
Figure 64 Middle East and Africa Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 65 Middle East and Africa Radiotherapy Market Share, By Type, 2024 & 2033 (%)
Figure 66 Middle East and Africa Radiotherapy Market Share, By Technology, 2024 & 2033 (%)
Figure 67 Middle East and Africa Radiotherapy Market Share, By Product Type, 2024 & 2033 (%)
Figure 68 Middle East and Africa Radiotherapy Market Share, By Form, 2024 & 2033 (%)
Figure 69 Middle East and Africa Radiotherapy Market Share, By End-User, 2024 & 2033 (%)
Figure 70 Accuracy Incorporated: Financials
Figure 71 Varian: Financials
Figure 72 Elekta AB: Financials
Figure 73 IBA (Ion Beam Applications): Financials
Figure 74 Mevion Medical Systems, Inc.: Financials
Figure 75 GE Healthcare: Financials
Figure 76 Hitachi, Ltd.: Financials
Figure 77 Canon Inc.: Financials
Figure 78 ViewRay Systems, Inc.: Financials
Figure 1 Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Radiotherapy Market Share, By Type, 2024 & 2033 (%)
Figure 3 Global Radiotherapy Market Share, By Technology, 2024 & 2033 (%)
Figure 4 Global Radiotherapy Market Share, By Product Type, 2024 & 2033 (%)
Figure 5 Global Radiotherapy Market Share, By Form, 2024 & 2033 (%)
Figure 6 Global Radiotherapy Market Share, By End-User, 2024 & 2033 (%)
Figure 7 Global Radiotherapy Market Share, By Region, 2024 & 2033 (%)
Figure 8 Global Radiotherapy Market Y-o-Y Growth, By Type, 2023-2033 (%)
Figure 9 Teletherapy (External) Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 10 Brachytherapy (Internal) Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 11 Systemic Radiation Therapy Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 12 Global Radiotherapy Market Y-o-Y Growth, By Technology, 2023-2033 (%)
Figure 13 Image-Guided Radiotherapy (IGRT) Technology in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 14 Intensity Modulated Radiotherapy (IMRT) Technology in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 15 Stereotactic Technology Technology in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 16 Proton Beam Therapy Technology in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 17 3d Conformal Radiotherapy (3d Crt) Technology in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 18 Others Technology in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 19 Global Radiotherapy Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 20 Compact Advanced Radiotherapy Systems Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 21 Proton Therapy Systems Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 22 Conventional Radiotherapy Systems Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 23 Lobenguane (I-131) Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 24 Samarium-153 Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 25 Rhenium-186 Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 26 Others Product Type in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 27 Global Radiotherapy Market Y-o-Y Growth, By Form, 2023-2033 (%)
Figure 28 X-rays Form in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 29 Gamma Rays Form in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 30 Particles Form in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 31 Global Radiotherapy Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 32 Hospitals End-User in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 33 Cancer Centers End-User in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 34 Others End-User in Global Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 35 Global Radiotherapy Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 36 North America Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 37 North America Radiotherapy Market Share, By Type, 2024 & 2033 (%)
Figure 38 North America Radiotherapy Market Share, By Technology, 2024 & 2033 (%)
Figure 39 North America Radiotherapy Market Share, By Product Type, 2024 & 2033 (%)
Figure 40 North America Radiotherapy Market Share, By Form, 2024 & 2033 (%)
Figure 41 North America Radiotherapy Market Share, By End-User, 2024 & 2033 (%)
Figure 42 North America Radiotherapy Market Share, By Country, 2024 & 2033 (%)
Figure 43 Asia-Pacific Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 44 Asia-Pacific Radiotherapy Market Share, By Type, 2024 & 2033 (%)
Figure 45 Asia-Pacific Radiotherapy Market Share, By Technology, 2024 & 2033 (%)
Figure 46 Asia-Pacific Radiotherapy Market Share, By Product Type, 2024 & 2033 (%)
Figure 47 Asia-Pacific Radiotherapy Market Share, By Form, 2024 & 2033 (%)
Figure 48 Asia-Pacific Radiotherapy Market Share, By End-User, 2024 & 2033 (%)
Figure 49 Asia-Pacific Radiotherapy Market Share, By Country, 2024 & 2033 (%)
Figure 50 Europe Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 51 Europe Radiotherapy Market Share, By Type, 2024 & 2033 (%)
Figure 52 Europe Radiotherapy Market Share, By Technology, 2024 & 2033 (%)
Figure 53 Europe Radiotherapy Market Share, By Product Type, 2024 & 2033 (%)
Figure 54 Europe Radiotherapy Market Share, By Form, 2024 & 2033 (%)
Figure 55 Europe Radiotherapy Market Share, By End-User, 2024 & 2033 (%)
Figure 56 Europe Radiotherapy Market Share, By Country, 2024 & 2033 (%)
Figure 57 South America Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 58 South America Radiotherapy Market Share, By Type, 2024 & 2033 (%)
Figure 59 South America Radiotherapy Market Share, By Technology, 2024 & 2033 (%)
Figure 60 South America Radiotherapy Market Share, By Product Type, 2024 & 2033 (%)
Figure 61 South America Radiotherapy Market Share, By Form, 2024 & 2033 (%)
Figure 62 South America Radiotherapy Market Share, By End-User, 2024 & 2033 (%)
Figure 63 South America Radiotherapy Market Share, By Country, 2024 & 2033 (%)
Figure 64 Middle East and Africa Radiotherapy Market Value, 2022-2033 (US$ Billion)
Figure 65 Middle East and Africa Radiotherapy Market Share, By Type, 2024 & 2033 (%)
Figure 66 Middle East and Africa Radiotherapy Market Share, By Technology, 2024 & 2033 (%)
Figure 67 Middle East and Africa Radiotherapy Market Share, By Product Type, 2024 & 2033 (%)
Figure 68 Middle East and Africa Radiotherapy Market Share, By Form, 2024 & 2033 (%)
Figure 69 Middle East and Africa Radiotherapy Market Share, By End-User, 2024 & 2033 (%)
Figure 70 Accuracy Incorporated: Financials
Figure 71 Varian: Financials
Figure 72 Elekta AB: Financials
Figure 73 IBA (Ion Beam Applications): Financials
Figure 74 Mevion Medical Systems, Inc.: Financials
Figure 75 GE Healthcare: Financials
Figure 76 Hitachi, Ltd.: Financials
Figure 77 Canon Inc.: Financials
Figure 78 ViewRay Systems, Inc.: Financials
